Prior authorization, step by step

Most GLP-1 prescriptions under Medicare require prior authorization. Here's exactly what that means and how to get to "approved."

Prior authorization (PA) is your plan's way of confirming a medication is medically appropriate before it agrees to cover it. Nearly every GLP-1 drug under Medicare Part D carries a PA requirement, and the Medicare GLP-1 Bridge program keeps it in place — the Bridge lowers your cost to a flat $50 monthly copay once you're approved, but it does not waive the review. For GLP-1 drugs, the plan wants to see a qualifying diagnosis, relevant lab values, and sometimes a record of other treatments you've tried.

Done right, the process is mostly paperwork your prescriber handles, and a straightforward request is often approved in a few days. The friction usually comes from small gaps — a missing lab value, a diagnosis code that doesn't line up with a covered indication, or a step-therapy rule nobody flagged in advance. This guide walks through what the plan actually needs, how long each stage takes, why requests get denied, and the full five-level appeal you're entitled to if the first answer is "no."

The 5 steps

  1. Your prescriber confirms a qualifying diagnosis. The diagnosis code on the request must match a covered indication — for the Bridge, that means one of the program's eligibility paths (for example, a BMI threshold with a related condition).
  2. They submit the PA request to your Part D plan. Usually electronically, with supporting clinical notes and the attestation that the drug is for its qualifying use.
  3. The plan reviews (typically within 72 hours; 24 hours if expedited). They may approve, deny, or ask for more information.
  4. If approved, you fill at an in-network pharmacy. Your covered copay applies — the flat $50 monthly copay under the Bridge. Approvals are often time-limited and need renewal, so note the expiration date.
  5. If denied, you appeal. You have the right to a five-level redetermination process — see below. A first denial is common and frequently reversed.

What your prescriber needs to include

You don't submit the PA yourself, but the request moves faster when your prescriber has the right pieces on the first try. If you're gathering information before your appointment, this is what the plan is generally looking for.

ItemWhy the plan wants it
Qualifying diagnosis & ICD-10 codeMust map to a covered indication; a mismatch here is the most common cause of denial.
Recent lab values (e.g., A1C, BMI)Documents that you meet the clinical threshold for the drug and, for the Bridge, an eligibility path.
Relevant history & comorbiditiesConditions such as heart disease, hypertension, or prediabetes can open a qualifying path.
Prior treatments triedAnswers any step-therapy requirement before the plan has to ask.
Your plan name & member IDSo the request routes to the correct Part D or Medicare Advantage plan.

Source: Documentation requirements per CMS.gov Part D coverage determination guidance. Specific criteria vary by plan — verify with yours.

How long it takes

Medicare sets firm deadlines for Part D coverage decisions. If your health could be seriously harmed by waiting, you or your prescriber can request an expedited review, which shortens the clock.

Request typePlan must decide withinWhen to use it
Standard determination72 hoursRoutine requests where a short wait is safe
Expedited determination24 hoursWhen waiting the standard time could seriously harm your health
Redetermination (1st appeal)7 days (standard)After a denial, filed within 60 days

Source: Timeframes per CMS.gov — Part D coverage determinations and appeals.

Common reasons PAs get denied

  • Diagnosis doesn't match a covered indication
  • Missing labs (e.g., A1C) or documentation
  • "Step therapy" — plan wants another drug tried first
  • Drug isn't on the plan's formulary
  • Quantity or dose outside plan limits

How to give yourself the best odds

  • Confirm the drug is on your formulary before the visit
  • Bring recent labs so nothing is missing at submission
  • Ask your prescriber for a letter of medical necessity up front
  • Note the approval's expiration date and renew early
  • Keep copies of every notice the plan sends you

If you're denied: the five-level Medicare appeal

A denial is not the end of the road. Medicare gives Part D members a formal, five-level appeals process, and a large share of GLP-1 denials are overturned once complete documentation and a letter of medical necessity are added. You generally have 60 days from each decision to move to the next level.

  1. Redetermination. Your plan re-reviews the request. File within 60 days of the denial; standard decisions come within 7 days.
  2. Reconsideration. An Independent Review Entity (IRE) — not your plan — takes a fresh look at the case.
  3. Administrative Law Judge (ALJ) hearing. Available when the amount in dispute meets a minimum threshold; you can present your case directly.
  4. Medicare Appeals Council review. The Council reviews the ALJ decision if you disagree with it.
  5. Federal district court. The final level, available above a higher dollar threshold.

Don't miss the 60-day window. The single most common reason a valid appeal fails is a missed deadline. Note the date on every denial notice, and if you need a fast decision because your health is at risk, ask for the appeal to be expedited.

Source: Five-level appeals structure per Medicare.gov and CMS.gov.

Frequently asked questions

Does the Bridge program remove prior authorization?

No. The Medicare GLP-1 Bridge lowers your out-of-pocket cost to a flat $50 monthly copay once you're approved, but your prescriber must still submit a prior authorization attesting that the drug is being used for its qualifying indication. The PA process is the same; the price after approval is what changes.

How long does a GLP-1 prior authorization take?

A standard Part D determination must be decided within 72 hours of the plan receiving the request. An expedited request — used when waiting could seriously harm your health — must be decided within 24 hours. You and your prescriber both get written notice.

My request was denied. Is it worth appealing?

Often, yes. Many first denials come from fixable gaps — a missing lab value or a diagnosis code that didn't map to a covered indication. Filing a redetermination within 60 days, with a letter of medical necessity and the missing documentation, reverses a meaningful share of them.

Do I have to renew an approved prior authorization?

Usually. GLP-1 approvals are commonly time-limited (for example, six or twelve months). Note the expiration date on your approval notice and ask your prescriber to renew before it lapses so your coverage doesn't have a gap.

Not sure you qualify yet?

Run the free eligibility check first — it'll tell you whether a prior authorization is even worth starting.

Check my eligibility →

Disclaimer: GLP1Bridge.com is an independent informational resource and is not affiliated with, endorsed by, or operated by Medicare, CMS, or any drug manufacturer. This is general education, not medical or legal advice. Timeframes and rules can change — verify with your plan and CMS.gov.